Functional antibody lacking a variable-region disulfide bridge.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMC 386825)

Published in Proc Natl Acad Sci U S A on October 01, 1986

Authors

S Rudikoff, J G Pumphrey

Articles by these authors

Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature (1984) 7.37

Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science (1995) 6.03

Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A (1989) 5.10

The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc Natl Acad Sci U S A (1974) 3.92

Genetics of a new IgVH (T15 idiotype) marker in the mouse regulating natural antibody to phosphorylcholine. J Exp Med (1974) 3.64

Growth of primary plasmacytomas in the mineral oil-conditioned peritoneal environment. J Natl Cancer Inst (1972) 3.01

Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol (1996) 3.01

The two-component, ATP-dependent Clp protease of Escherichia coli. Purification, cloning, and mutational analysis of the ATP-binding component. J Biol Chem (1988) 2.95

Sequence and structure of Clp P, the proteolytic component of the ATP-dependent Clp protease of Escherichia coli. J Biol Chem (1990) 2.71

Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A (1997) 2.36

VH genes encoding the immune response to beta-(1,6)-galactan: somatic mutation in IgM molecules. EMBO J (1984) 1.98

The galactan-binding immunoglobulin Fab J539: an X-ray diffraction study at 2.6-A resolution. Proteins (1986) 1.96

Immunoglobulin structure: amino terminal sequences of mouse myeloma proteins that bind phosphorylcholine. Science (1974) 1.94

Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93

Structural evidence for independent joining region gene in immunoglobulin heavy chains from anti-galactan myeloma proteins and its potential role in generating diversity in complementarity-determining regions. Proc Natl Acad Sci U S A (1979) 1.89

Monoclonal antibodies to DNA and RNA from NZB/NZW F1 mice: antigenic specificities and NH2 terminal amino acid sequences. J Immunol (1984) 1.69

Structural basis for the specificity of phosphorylcholine-binding immunoglobulins. Immunochemistry (1976) 1.63

Nucleic acid and protein sequences of phosphocholine-binding light chains. J Exp Med (1981) 1.61

Structure at 4.5 A resolution of a phosphorylcholine-binding fab. Nat New Biol (1973) 1.60

Somatic diversification of immunoglobulins. Proc Natl Acad Sci U S A (1984) 1.59

Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immunol (1987) 1.55

Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med (1995) 1.49

Single amino acid substitution altering antigen-binding specificity. Proc Natl Acad Sci U S A (1982) 1.46

Spectral changes on binding of oligosaccharides to murine immunoglobulin A myeloma proteins. Biochemistry (1973) 1.45

In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol (1989) 1.41

Somatic mutation in a cultured mouse myeloma cell affects antigen binding. Proc Natl Acad Sci U S A (1982) 1.39

Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. Hum Gene Ther (1998) 1.39

Structural requirements for the binding of derivatives of D-galactose to two homogeneous murine immunoglobulins. Biochemistry (1974) 1.38

Crystals of phosphorylcholine-binding Fab-fragments from mouse myeloma proteins: preparation and x-ray analysis. Proc Natl Acad Sci U S A (1972) 1.34

Structure and expression of two porcine genomic clones encoding class I MHC antigens. J Immunol (1985) 1.32

Variable region sequence of the heavy chain from a phosphorylcholine binding myeloma protein. Biochemistry (1974) 1.31

Galactan-binding antibodies. Diversity and structure of idiotypes. J Exp Med (1983) 1.30

Formation of needle-like aggregates in stirred solutions of hemoglobin S1. Biochem Biophys Res Commun (1976) 1.29

Size differences among immunoglobulin heavy chains from phosphorylcholine-binding proteins. Proc Natl Acad Sci U S A (1976) 1.27

Polymorphism in immunoglobulin heavy chains suggesting gene conversion. Proc Natl Acad Sci U S A (1982) 1.24

Purification and properties of Gal repressor:pL-galR fusion in pKC31 plasmid vector. J Biol Chem (1987) 1.23

Six BALB-c IgA myeloma proteins that bind beta-(1-6)-D-galactan. Partial amino acid sequences and idiotypes. J Exp Med (1973) 1.22

Polymorphism in anti-phosphocholine antibodies reflecting evolution of immunoglobulin families. J Exp Med (1983) 1.21

T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. J Immunol (1989) 1.20

Insulin-like growth factor I is a dual effector of multiple myeloma cell growth. Blood (2000) 1.17

k Chain variable regions from three galactan binding myeloma proteins. Biochemistry (1978) 1.17

kappa Chain joining segments and structural diversity of antibody combining sites. Proc Natl Acad Sci U S A (1980) 1.13

A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo. Endocrinology (1999) 1.13

Immunoglobulin structure--function correlates: antigen binding and idiotypes. Contemp Top Mol Immunol (1983) 1.12

Characterization of a porcine genomic clone encoding a major histocompatibility antigen: expression in mouse L cells. Proc Natl Acad Sci U S A (1982) 1.12

kappa Chain variable region from M167, a phosphorylcholine binding myeloma protein. Biochemistry (1978) 1.07

Sequence variation among heavy chains from inulin-binding myeloma proteins. Proc Natl Acad Sci U S A (1978) 1.06

Relationships between B cell and myeloid differentiation. Studies with a B lymphocyte progenitor line, HAFTL-1. J Exp Med (1988) 1.05

Evidence for gene conversion among immunoglobulin heavy chain variable region genes. J Exp Med (1984) 1.05

In vitro culture of primary plasmacytomas requires stromal cell feeder layers. Proc Natl Acad Sci U S A (1993) 1.05

Genetic basis for expression of the idiotypic network. One unique Ig VH germline gene accounts for the major family of Ab1 and Ab3 (Ab1') antibodies of the GAT system. J Exp Med (1986) 1.04

T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc Natl Acad Sci U S A (1995) 1.04

Crystallization of sickle hemoglobin from gently agitated solutions--an alternative to gelation. J Mol Biol (1977) 1.03

Characterization of the developmentally regulated Bacillus subtilis glucose dehydrogenase gene. J Bacteriol (1986) 1.01

Allelic forms of the immunoglobulin heavy chain variable region. J Immunol (1980) 1.00

Structural, functional, and idiotypic characteristics of a phosphorylcholine-binding IgA myeloma protein of C57BL/ka allotype. J Exp Med (1975) 0.99

Genetics of susceptibility to plasmacytoma induction. I. BALB/cAnN (C), C57BL/6N (B6), C57BL/Ka (BK), (C times B6)F1, (C times BK)F1, and C times B recombinant-inbred strains. J Natl Cancer Inst (1975) 0.99

kappa-Chain restriction in anti-galactan antibodies. J Immunol (1982) 0.98

VL-VH expression by monoclonal antibodies recognizing avian lysozyme. J Immunol (1984) 0.96

An IgM Waldenström with specificity against phosphorylcholine. Biochemistry (1975) 0.95

Contribution of the VK4 light chain to antibody specificity for lysozyme and beta (1,6)D-galactan. Mol Immunol (1986) 0.94

Murine plasma cells secreting more than one class of immunoglobulin heavy chain. I. Frequency of two or more M-components in ascitic fluids from 788 primary plasmacytomas. J Immunol (1976) 0.94

Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state. Ann N Y Acad Sci (1989) 0.94

Characterization of a new subfamily of class I genes in the H-2 complex of the mouse. Immunogenetics (1988) 0.93

Interaction and sequence diversity among T15 VH genes in CBA/J mice. J Exp Med (1988) 0.93

Heavy-chain variable-region sequence from an inulin-binding myeloma protein. Biochemistry (1977) 0.92

Identification of cysteine 656 as the amino acid of hepatoma tissue culture cell glucocorticoid receptors that is covalently labeled by dexamethasone 21-mesylate. J Biol Chem (1987) 0.91

Amino acids at the site of V kappa-J kappa recombination not encoded by germline sequences. J Exp Med (1987) 0.91

Uniformity in a clonal repertoire: a case for a germ-line basis of antibody diversity. Cold Spring Harb Symp Quant Biol (1977) 0.90

Chromosomal translocations deregulating c-myc are associated with normal immune responses. Oncogene (1997) 0.90

Structural evidence for a polymorphic or allelic form of the heavy chain variable region. J Immunol (1979) 0.89

Crystal structure of galactan-binding mouse immunoglobulin J539 Fab at 4.5-A resolution. Proc Natl Acad Sci U S A (1979) 0.89

Distinct tumorigenic potential of abl and raf in B cell neoplasia: abl activates the IL-6 signaling pathway. Immunity (1996) 0.89

Localized deletion-insertion mutations: a major factor in the evolution of immunoglobulin structural variability. J Immunol (1976) 0.89

Expression of equivalent clonotypes in BALB/c and A/J mice after immunization with phosphorylcholine. J Exp Med (1976) 0.88

Idiotypic self binding of a dominant germline idiotype (T15). Autobody activity is affected by antibody valency. J Exp Med (1987) 0.88

Primary structural differences in myeloma proteins that bind the same haptens. Cold Spring Harb Symp Quant Biol (1977) 0.88

Structural and genetic basis of idiotypy in the galactan-binding myeloma proteins. Ann Immunol (Paris) (1979) 0.87

Biological and chemical properties of natural antibodies in the nurse shark. J Immunol (1970) 0.87

Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo. Oncogene (2000) 0.86

Allelic forms of anti-phosphorylcholine antibodies. J Immunol (1981) 0.86

Kappa chain structure from a crystallized murine Fab': role of joining segment in hapten binding. Mol Immunol (1981) 0.85

Transplantation in miniature swine. IX. Swine histocompatibility antigens: isolation and purification of papain-solubilized SLA antigens. J Immunol (1981) 0.85

Gene correction in the evolution of the T cell receptor beta chain. J Exp Med (1986) 0.85

The structural basis of a hapten-inhibitable kappa-chain idiotype. J Immunol (1979) 0.85

Oxygen equilibrium of emulsified solutions of normal and sickle hemoglobin. Biochem Biophys Res Commun (1979) 0.84

Structure and expression of class I MHC genes in the miniature swine. Vet Immunol Immunopathol (1987) 0.83

The murine Il-6 gene maps to the proximal region of chromosome 5. J Immunol (1989) 0.83

Instability of immunoglobulin genes in S107 cell line. Somat Cell Mol Genet (1991) 0.82

Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments. J Immunol (1984) 0.82

Evolution of a V kappa gene family. Immunogenetics (1986) 0.81

Modern evolution of a single-copy gene: the immunoglobulin C kappa locus in wild mice. Mol Biol Evol (1988) 0.81

Susceptibility and resistance to J3V1 retrovirus-induced murine plasmacytomagenesis in reconstituted severe combined immunodeficient mice. Oncogene (1993) 0.81

Disseminated growth of murine plasmacytoma: similarities to multiple myeloma. Cancer Res (1998) 0.81

Comparative ligand-binding by purified nurse shark natural antibodies and anti-2,4-dinitrophenyl antibodies from other species. J Immunol (1971) 0.80

Specific association of repetitive DNA sequences with major histocompatibility genes. Mol Cell Biol (1983) 0.80